Others titles

Medicare Part D Prescriber Public Use File Data 2016
Medicare Provider Utilization and Payment Part D Prescriber Data 2016

Keywords

Prescriber Data
Prescription Drug Plans
Medicare Part D
Medicare Advantage
Medicare Prescription Drug Coverage
Medicare Claims Data
Provider Summary

Medicare Part D Prescriber Utilization and Payment Data 2016

Name: Medicare Part D Prescriber Utilization and Payment Data 2016
Creator: John Snow Labs

The Medicare Part D Prescriber Public Use File provides information on prescription drug events (PDEs) incurred by Medicare beneficiaries with a Part D prescription drug plan for the year 2016. The Part D Prescriber PUF is organized by National Provider Identifier (NPI) and drug name and contains information on drug utilization (claim counts and day supply) and total drug costs.

Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.

Your Data License

Research
Non-Commercial, Share-Alike, Attribution Free Forever
Commercial
Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Standard End User License Agreement (“EULA”) applies to customers of John Snow Labs Inc. (as defined below), using any product of John Snow Labs Inc. on John Snow Labs Marketplace as defined below (hereinafter referred to “you”) and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading, installing, and/or using (as applicable) any Product of John Snow Labs (as defined below), you automatically agree to be bound by, and use our Products in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE PURCHASING, INSTALLING OR USING OUR PRODUCTS MADE AVAILABLE ON JOHN SNOW LABS MARKETPLACE.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of our Products after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“John Snow Labs Data Library” means a data library located at https://www.johnsnowlabs.com;

“Products” means products and services of John Snow Labs that you download and use from listings in John Snow Labs Data Library;

Important Notice

By installing and using our Products, you acknowledge that the use of the Products can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use the Products for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Products can be used by an individual, business or other legal entity, or both. If you are entering into this EULA, or using the Products, on behalf of a company or other legal entity, you represent that you have the authority to bind such entity to this EULA, in which case “you” shall refer to such entity.

In the event you have entered into a separate written agreement with John Snow Labs regarding the Products that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all.

Your Access and Use

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, license to install, access to, modify, and use of, the Products worldwide (subject to applicable export laws) during the term of this EULA (as described below) solely for research, private study and personal use of Products.

This license is personal to you, and you may not resell our Products, permit other users access to our Products through your account. Your right to use our Products is limited by all terms and conditions set forth in this EULA.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Products, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Products are protected by applicable intellectual property laws, including United States copyright law and international treaties.

Except for the foregoing license, you have no other rights in the Products and you may not modify, edit, copy, reproduce, create derivative works of, reverse engineer, alter, enhance or in any way exploit the Products in any manner. If you breach any of this EULA, the above license will terminate automatically.

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of the Products. You are responsible for end users’ use of your content and the Products. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and the Products by such end user. We do not provide any support or services to end users unless we have a separate agreement with you or an end user obligating us to provide such support or services.

Restrictions

You will access or use our Products solely via John Snow Labs Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

reproduce, modify, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of any of our Products or its technological features or measures;
rent, lease, sell, resell, loan, distribute, or sublicense access to any of our Products;
circumvent or disable any security or technological features or measures of our Products;
use our intellectual property rights without our express prior written authorization;
use our Products for more than one trial period, unless the trial period is extended by John Snow Labs’ prior written permit;
use our Products with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of the Products;
store, copy, modify, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on our Products (collectively, “Content”) or compile or collect any Content as part of a database or other work;
use any automated tool (e.g., robots, spiders) to access or use our Products, or to store, copy, modify, distribute, or resell any Content;
circumvent or disable any rights management, usage rules, or other security features of our Products;
use our Products in a manner that overburdens, or that threatens the integrity, performance, or availability of, our Products; or
remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Fees and Taxes

Your use of the Products is subject to our fees. All fees are given on our website https://www.johnsnowlabs.com. Except as set forth in this EULA, the fees are non-refundable. We are entitled to revise our fees from time to time.

The fees exclude any federal, state or local taxes, VAT, GST, or similar taxes. You are responsible for identification and payment of all taxes as required by applicable law.

Term and Termination

This EULA will become effective as of the date of your order of Products and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use our Products, if you or your end user’s use of the Products:

is in breach of this EULA;
poses a security risk to our Products;
could adversely impact our systems, the Products or other customers;
could subject us, our affiliates, or any third party to liability; or
could be fraudulent.

We may also suspend or terminate your right to use our Products, if you fail to perform your payment obligations, or you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

We may also suspend or terminate your right to use our Products without any reason upon a relevant 30 days’ written notice to you and will refund the unused fees pre-paid by you for access to the Products for the affected time period (if any). Where your access is suspended or terminated by the breach of this EULA or applicable laws, John Snow Labs will will not provide, or be liable for, any refund.

You will cease use of the Products during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Support

If applicable to your Product, John Snow Labs will provide you with the support services. If you use a trial access, support services are excluded. Under this EULA, our support services exclude any installation, training, maintenance services (including any error corrections, bug fixes, or new releases), technical assistance, consulting services, or other services of any kind. Such services are provided at John Snow Labs’ discretion.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Access to our Products

We do not provide you with the equipment to access our Products. You are responsible for all fees charged by third parties related to your access and use of our Products (e.g., charges by Internet service providers).

You are responsible for monitoring your use of the Products, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of the Products for auditing purposes.

You also certify that you are legally permitted to use the Products, and take full responsibility for the selection and use of the Products. This EULA is void where prohibited by law, and the right to use the Products is revoked in such jurisdictions. John Snow Labs makes no claim that the Products may be lawfully used outside of the United States. If you use the Products from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Our Products may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using our Products (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using our Products, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

The Products, including software, is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to the Products or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on our Products are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of our Products, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs and may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in our Products are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF THE PRODUCTS IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of the Products; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of the Products will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Products. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about our Products or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

The Part D Prescriber Public Use File (PUF) provides information on prescription drugs prescribed by individual physicians and other healthcare providers and paid for under the Medicare Part D Prescription Drug Program. The Part D Prescriber PUF is based on information from CMS’s Chronic Conditions Data Warehouse, which contains Prescription Drug Event records submitted by Medicare Advantage Prescription Drug (MAPD) plans and by stand-alone Prescription Drug Plans (PDP). The dataset identifies providers by their National Provider Identifier (NPI) and the specific prescriptions that were dispensed at their direction, listed by brand name (if applicable) and generic name. For each prescriber and drug, the dataset includes the total number of prescriptions that were dispensed, which include original prescriptions and any refills, and the total drug cost. The total drug cost includes the ingredient cost of the medication, dispensing fees, sales tax, and any applicable administration fees and is based on the amount paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers.

Although the Part D Prescriber PUF has a wealth of information on payment and utilization for Medicare Part D prescriptions, the dataset has a number of limitations. Of particular importance is the fact that the data may not be representative of a physician’s entire practice or all of Medicare as it only includes information on beneficiaries enrolled in the Medicare Part D prescription drug program (i.e., approximately two-thirds of all Medicare beneficiaries).

About this Dataset

Data Info

Date Created	2018-03-22
Last Modified	2018-11-14
Version	2018-11-14
Update Frequency	Annual
Temporal Coverage	2016
Spatial Coverage	United States
Source	John Snow Labs; Centers for Medicare and Medicaid Services;
Source License URL
Source License Requirements	N/A
Source Citation	N/A
Keywords	Prescriber Data, Prescription Drug Plans, Medicare Part D, Medicare Advantage, Medicare Prescription Drug Coverage, Medicare Claims Data, Provider Summary
Other Titles	Medicare Part D Prescriber Public Use File Data 2016, Medicare Provider Utilization and Payment Part D Prescriber Data 2016

Data Fields

Name	Description	Type	Constraints
National_Provider_Identifier	National Provider Identifier (NPI) for the performing provider on the claim.	string	-
Last_Name_Organization_Name	When the provider is registered in NPPES as an individual, this is the provider’s last name. When the provider is registered as an organization, this is the organization name.	string	-
First_Name	When the provider is registered in NPPES as an individual, this is the provider’s first name. When the provider is registered as an organization, this will be blank.	string	-
City	The city where the provider is located, as reported in NPPES	string	-
State_Abbreviation	The state where the provider is located, as reported in NPPES. The fifty U.S. states and the District of Columbia are reported by the state postal abbreviation. “XX” = “Unknown” “AA” = “Armed Forces Central/South America” “AE” = “Armed Forces Europe” “AP” = “Armed Forces Pacific” “AS” = “American Samoa” “GU” = “Guam” “MP” = “Northern Mariana Islands” “PR” = “Puerto Rico” “VI” = “Virgin Islands” “ZZ” = “Foreign Country”	string	-
Speciality_Description	Speciality_description is derived from the Medicare provider/supplier specialty code reported on the NPI’s Part B claims. For providers that have more than one Medicare specialty code reported on their claims, the Medicare specialty code associated with the largest number of services is reported. Where a prescriber’s NPI did not have associated Part B claims, the taxonomy code associated with the NPI in NPPES is mapped to a Medicare specialty code using an external crosswalk. For any taxonomy codes that could not be mapped to a Medicare specialty code, the taxonomy classification description from the National Uniform Claim Committee (NUCC) taxonomy code set is used.	string	-
Description_Flag	A flag that indicates the source of the specialty_description. “S” = Medicare Specialty Code description “T” = Taxonomy Code Classification description.	string	-
Drug_Name	The name of the drug filled. This includes both brand names (drugs that have a trademarked name) and generic names (drugs that do not have a trademarked name).	string	-
Generic_Name	A term referring to the chemical ingredient of a drug rather than the trademarked brand name under which the drug is sold.	string	-
Beneficiaries_Count	The total number of unique Medicare Part D beneficiaries with at least one claim for the drug. Counts fewer than 11 are suppressed and are indicated by a blank.	integer	level : Ratio
Total_Claim_Count	The number of Medicare Part D claims. This includes original prescriptions and refills. Aggregated records based on total_claim_count fewer than 11 are not included in the data file.	number	level : Ratio
Total_30_Day_Fill_Count	The aggregate number of Medicare Part D standardized 30-day fills. The standardized 30-day fill is derived from the number of days supplied on each Part D claim divided by 30. Standardized 30-day fill values less than 1.0 were bottom-coded with a value of 1.0 and standardized 30day fill values greater than 12.0 were top-coded with a value of 12.0.	number	level : Ratio
Total_Day_Supply	The aggregate number of day’s supply for which this drug was dispensed.	number	level : Ratio
Total_Drug_Cost	The aggregate total drug cost paid for all associated claims. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees. The total drug cost is based on the amounts paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers.	number	-
Beneficiary_Count_Of_Age_65	The total number of unique Medicare Part D beneficiaries age 65 and older with at least one claim for the drug. A blank indicates the value is suppressed	integer	level : Ratio
Supression_Reason_Of_Beneficiary_Count_Age_65	A flag indicating the reason the bene_count_ge65 variable is suppressed. * = Primary suppressed due to bene_count_ge65 between 1 and 10. # = Counter suppressed because the “less than 65 year old” group (not explicitly displayed) contains a beneficiary count between 1 and 10, which can be mathematically determined from bene_count_ge65 and bene_count.	string	-
Total_Claim_Count_Age65_And_Older	The number of Medicare Part D claims for beneficiaries age 65 and older. This includes original prescriptions and refills. A blank indicates the value is suppressed. See ge65_suppress_flag regarding suppression of data.	number	level : Ratio
Supression_Reason_Aged65_And_Older	A flag that indicates the reason the total_claim_count_ge65, total_30_day_fill_count ge65, total_day_supply_ge65, and total_drug_cost_ge65 variables are suppressed. * = Primary suppressed due to total_claim_count_ge65 between 1 and 10. “#” = Counter suppressed because the “less than 65 year old” group (not explicitly displayed) contains a small claim count between 1 and 10, which can be mathematically determined from the total_claim_count_ge65 and total_claim_count.	string	-
Total_30Day_Fill_Count_Aged65_And_Older	The number of Medicare Part D standardized 30-day fills for beneficiaries age 65 and older. The standardized 30-day fill is derived from the number of days supplied on each Part D claim divided by 30. Standardized 30-day fill values less than 1.0 were bottom-coded with a value of 1.0 and standardized 30-day fill values greater than 12.0 were top-coded with a value of 12.0. If total_claim_count_ge65 is suppressed, this variable is suppressed. A blank indicates the value is suppressed. See ge65_suppress_flag regarding suppression of data.	number	level : Ratio
Total_Day_Supply_Aged65_And_Older	The aggregate number of day’s supply for which this drug was dispensed, for beneficiaries age 65 and older. If total_claim_count_ge65 is suppressed, this variable is suppressed. A blank indicates the value is suppressed. See ge65_suppress_flag regarding suppression of data.	number	level : Ratio
Total_Drug_Cost_Aged65_And_Older	The aggregate total drug cost paid for all associated claim for beneficiaries age 65 and older. This amount includes ingredient cost, dispensing fee, sales tax, and any applicable vaccine administration fees and is based on the amounts paid by the Part D plan, Medicare beneficiary, government subsidies, and any other third-party payers. If total_claim_count_ge65 is suppressed, this variable is suppressed. A blank indicates the value is suppressed. See ge65_suppress_flag regarding suppression of data.	number	-

Data Preview

National Provider Identifier

Last Name Organization Name

First Name

City

State Abbreviation

Speciality Description

Description Flag

Drug Name

Generic Name

Beneficiaries Count

Total Claim Count

Total 30 Day Fill Count

Total Day Supply

Total Drug Cost

Beneficiary Count Of Age 65

Supression Reason Of Beneficiary Count Age 65

Total Claim Count Age65 And Older

Supression Reason Aged65 And Older

Total 30Day Fill Count Aged65 And Older

Total Day Supply Aged65 And Older

Total Drug Cost Aged65 And Older

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

ATORVASTATIN CALCIUM

450

139.32

13.0

15.0

450.0

139.32

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

CIPROFLOXACIN HCL

80.99

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

DOXYCYCLINE HYCLATE

20.0

199

586.12

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

ELIQUIS

APIXABAN

510

6065.02

17.0

510.0

6065.02

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

FUROSEMIDE

12.0

405

45.76

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

HYDRALAZINE HCL

420

169.48

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

ISOSORBIDE MONONITRATE ER

ISOSORBIDE MONONITRATE

16.0

1005

372.63

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

LEVOFLOXACIN

26.0

159

222.41

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

LISINOPRIL

14.0

960

129.24

1003000126

ENKESHAFI

ARDALAN

CUMBERLAND

Internal Medicine

METOPROLOL TARTRATE

14.0

1050

183.29

14.0

33.0

37.0

1050.0

183.29